A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Osteoarthritis; Avascular Necrosis
Intervention: Oxford® Meniscal Unicompartmental Knee System (Device)
Phase: N/A
Status: Recruiting
Sponsored by: Biomet Orthopedics, LLC Overall contact:
Tracy Johnson, Phone: 1-800-348-9500, Email: tracy.johnson@biometmail.com
Summary
The purpose of this study is to collect information on complications and survivorship of
patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites
in the United States.
Clinical Details
Official title: A Prospective, Non-Randomized, Multicenter Study of the Oxford® Meniscal Unicompartmental Knee System
Study design: Treatment, Non-Randomized, Open Label, Single Group Assignment
Primary outcome: Complications, Survival
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with one of the following diagnoses in the medial compartment of the knee:
Osteoarthritis, Avascular Necrosis
Exclusion Criteria:
- Patients with Rheumatoid arthritis or other forms of inflammatory joint disease
- Patients with infection, sepsis, and osteomyelitis
- Patients with Osteoporosis, Paget's Disease, Charcot's disease, Osteomalacia, and
Severe Osteoporosis
Locations and Contacts
Tracy Johnson, Phone: 1-800-348-9500, Email: tracy.johnson@biometmail.com
Biomet Orthopedics, LLC, Warsaw, Indiana 46581, United States; Recruiting
Jarsie Weeks, Phone: 800-348-9500, Email: jarsie.weeks@biomet.com
Additional Information
Starting date: March 2006
Ending date: December 2017
Last updated: July 3, 2008
|
